• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Tracey Technologies Upgrades iTrace Software

    Foster Corporation Rebrands its Distribution Business

    Greenleaf Health Recruits Two Former FDA Officials

    TOTAL Toric Contact Lenses for Astigmatism Debuts in Canada

    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Timeline Mystery for Updated EtO Rules

    An Update on Hospital Trends Post-Pandemic

    Don’t Fear the Audit: Benefits of Good Quality Practices

    Understanding the FDA’s Standards & Conformity Assessment Program

    Medtech Divestitures Are Good for Medtech Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Designing for Manufacturing: 5 Common Startup Mistakes (and How to Avoid Them)

    5 Challenges Medtech Must Address to Transform Healthcare

    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Novel Polymers for Sustained Release: Trends Impacting the Drug Delivery Market

    An interview with ProMed Pharma's director of pharma services James Arps analyzes the diverse drug delivery/combination products market.

    Novel Polymers for Sustained Release: Trends Impacting the Drug Delivery Market
    Sam Brusco, Associate Editor11.15.19
    The drug delivery and combination products market is made up of a number of markets, all based on the means by which the drug is delivered. Some are administered through injection, some through infusion, some orally, some transdermally, and the list continues. Nanomedicine and nano delivery systems are emerging as a method of targeted drug delivery, in which particles attracted to diseases cells directly treat those cells. Implant technology can also deliver targeted medication, providing longer-lasting, localized therapy.
     
    In order to gain more insights about the trends and challenges affecting the diverse drug delivery and combination products markets, I spoke to James Arps, Ph.D., director of pharma services at ProMed Pharma LLC, a Minneapolis, Minn.-based contract manufacturer of polymer-based drug releasing molded dosage forms and combination device components. A portion of his input was included in the November/December issue feature article “Delivering the Goods: The Evolving World of Combination Products.” The entirety of our interview is featured here.

    Sam Brusco: What were the trends that drove the biopharma and drug delivery/combination product markets in 2019?
     
    James Arps, Ph.D.: We focus on sustained release complex dosage forms and drug/device combination products, essentially, we’re looking at ways to keep from forcing patients to take a daily pill or visit the clinic for a weekly or monthly injection. Patients simply don’t want to do these things, which impacts how well the therapy works.
     
    The industry has been focusing more on sustained release applications due to the rise of some innovative technologies. For example, a company has developed a novel once-a-month pill that utilizes an interesting polymer drug release technology for a number of applications.
     
    We also notice significant interest in pain management alternatives due to the opioid crisis. We’ve seen neurostimulation devices that mask the pain by stimulating the spinal cord, as well as sustained release, non-opioid drug-eluting implants that deliver locally to the region of the pain. These technologies have been used for applications like treating post-knee-surgery pain and sciatic nerve-based lower back pain.
     
    Brusco: Which latest developments and/or innovations in drug delivery technology/combination products have captured your attention?
     
    Dr. Arps: A particular class of drug delivery technologies involves sustained release, long-acting implants implanted underneath the skin. These have a long history, particularly in the area of contraception. Most of these are composed of durable polymers like silicones or ethylene vinyl acetate.
     
    The preferred approach to using these devices is a low-effort one: implant it, have it release the drug, then it will slowly dissolve away so you never have to worry about taking it out. And if you want a new one implanted after a year or two, that can be done. Unfortunately, the number of resorbable polymers on the market has been limited, and these polymers don’t always have the best properties for the application.
     
    We’re working with a couple of companies with new polymer technologies that are much more effective for sustained release. These polymers maintain mechanical integrity over a longer period of time and slowly dissolve away like a bar of soap while the drug is released. For example, we have a public strategic partnership with DSM Biomedical, who has developed a polymer called polyester amide (PEA) that has some novel resorption properties.
     
    Brusco: What effect is the convergence of pharma and medtech having on the medical device industry?
     
    Dr. Arps: From a regulatory standpoint, the medtech-pharma convergence is evident simply because it’s a combination product. In the U.S., the FDA’s Office of Combination Products regulates these technologies. This office pulls in people from both the pharma and medical device regulatory groups. Because of that convergence, pharma has recruited quality personnel associated with the medical device industry. It is important to have this perspective because the pharma industry hasn’t previously had to deal with medical device regulatory constraints like design master files.
     
    The medical device side has to engage higher levels of pharma requirements like data integrity. When testing combination products, how data is managed, maintained, and protected for both development and the commercial manufacture is crucial. FDA is also paying more attention to how we manage and approve suppliers to ensure components going into drug-device combination products are high-quality and appropriately controlled.
     
    Brusco: How does the approach to designing, manufacturing, and/or testing a drug delivery device/combination product (or components that go into these devices) differ from other medtech products?
     
    Dr. Arps: Quality by design is a huge buzzword in the pharma world, and that is starting to migrate more into the medical device world. It’s important to lay out the target product profile andthe critical quality attributes of the product we’re developing with our partners. Trying to draft process FMEAs early on, and anticipate where the potential bottlenecks and challenges will be.
     
    The other piece with a combination product is a lot of analytical testing to characterize how the drug comes out of it, and if any of the processing of the drug into the device can degrade the drug at all. We have an in-house analytical lab with a lot of experience specific to some of these long-acting implants and combination products, so we can very quickly develop and test new formulations. We have a good efficiency backloop on that.
     
    Brusco: What are the challenges and opportunities for drug delivery and combination products in the next few years?
     
    Dr. Arps: Everyone has their own particular “mousetrap” and a way of doing things. We want to be able to tailor our solutions to the particular customer’s needs and to come up with an efficient development and manufacturing timeline for them. Speed to market is still a huge consideration, and part of that is speed to clinical trial. Once a decision is made that you’re happy with this formulation, you must move as quickly as possible to get into clinical studies with the appropriate safety profile, and have all the details worked out at the appropriate time.
     
    Brusco: Is there anything else you’d like to say regarding the manufacturing of drug delivery/combination products or components?
     
    Dr. Arps: When trying to establish a partnership with a company in this field, look at their background and experience. We have a history of manufacturing these products—to our knowledge we were the first contract manufacturer to make drug-device combination component like steroid-eluting leadss for cardiac pacing. We were the first one in the U.S. to really establish that—before, it was all the final device manufacturer. Being the first contract manufacturer with the quality systems and manufacturing processes in place to handle these was key.
     
    We’ve also embraced having experience with a wide range of polymers and active pharmaceutical ingredients for drug delivery because the various drugs interact differently with each polymer. That background experience has been helpful to moving development forward as quickly as possible.
    Related Searches
    • implant
    • medical
    • development
    • technology
    Related Knowledge Center
    • Materials
    Suggested For You
    CE Mark Granted to Expandable, Biodegradable Biliary Stent CE Mark Granted to Expandable, Biodegradable Biliary Stent
    Smaller Devices Require More Efficient Material Integration Smaller Devices Require More Efficient Material Integration
    Phillips-Medisize Unveils Aria Smart Autoinjector Platform Phillips-Medisize Unveils Aria Smart Autoinjector Platform
    EAG Expands Medical Device Testing Services With New Lab EAG Expands Medical Device Testing Services With New Lab
    Summit Partners Invests in Veranex Summit Partners Invests in Veranex
    FDA Making Progress With Technology and Data Action Plans FDA Making Progress With Technology and Data Action Plans
    OrthogenRx on FDA’s Ambiguity on Hyaluronic Acid OrthogenRx on FDA’s Ambiguity on Hyaluronic Acid
    New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    Pharmaceutical Focus: A Look at Combination Products Pharmaceutical Focus: A Look at Combination Products
    Engineering and Manufacturing Partnerships: The Key to Successful Combination Products Engineering and Manufacturing Partnerships: The Key to Successful Combination Products
    Combination Products Update—Mike on Medtech Combination Products Update—Mike on Medtech
    The Medtech Supply Chain and COVID-19 The Medtech Supply Chain and COVID-19
    Smart Devices and Drug Formulations: Trends Affecting the Combination Products Market Smart Devices and Drug Formulations: Trends Affecting the Combination Products Market
    Connectivity and Biologics: Trends Impacting the Drug-Device Combo Product Market Connectivity and Biologics: Trends Impacting the Drug-Device Combo Product Market
    5 Questions for DSM at Medica/CompaMed 2019 5 Questions for DSM at Medica/CompaMed 2019

    Related Breaking News

    • CE Mark Granted to Expandable, Biodegradable Biliary Stent

      CE Mark Granted to Expandable, Biodegradable Biliary Stent

      The UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent is intended to facilitate the drainage of obstructed ducts requiring larger openings.
      PR Newswire 09.07.21

    • Materials
      Smaller Devices Require More Efficient Material Integration

      Smaller Devices Require More Efficient Material Integration

      Silicones are becoming increasingly well-suited for implantable medical devices and combination products.
      Michael Barbella, Managing Editor 08.03.21

    • Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Phillips-Medisize Unveils Aria Smart Autoinjector Platform

      Small and easy-to-use injection device is designed to support medication management.
      Phillips-Medisize 08.02.21


    • Testing
      EAG Expands Medical Device Testing Services With New Lab

      EAG Expands Medical Device Testing Services With New Lab

      The laboratory includes a dedicated medical device polymer analysis area.
      Business Wire 07.12.21

    • Summit Partners Invests in Veranex

      Summit Partners Invests in Veranex

      Investment will form a concept-to-commercialization medtech services company.
      Veranex 06.21.21

    Loading, Please Wait..

    Trending
    • Medinbox And Abbott Partner To Increase Efficiency In Electrophysiology Labs
    • Masimo Reveals Freedom Health-Tracking Smartwatch
    • FDA OKs FemDx Medsystems' FalloView Device
    • Getinge’s Cardiosave Faces CE-Certificate Suspension From TÜV SÜD
    • A New Approach To Post-Market Surveillance
    Breaking News
    • Tracey Technologies Upgrades iTrace Software
    • Foster Corporation Rebrands its Distribution Business
    • Greenleaf Health Recruits Two Former FDA Officials
    • TOTAL Toric Contact Lenses for Astigmatism Debuts in Canada
    • FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    View Breaking News >
    CURRENT ISSUE

    March 2023

    • Sensing Technology Drives the Future of Medical Care
    • New and Developing Diabetes Technologies Offer 'Sweet Relief'
    • Discussing Matters of Substance in Medtech Materials
    • Medical Device Testers Are Caught Up in a Whirlwind
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Hyaluronic Acid Ingredient Linked to Antioxidant Benefits In Vitro
    Anita Johansen Appointed New CEO of Probi
    Kemin Human Nutrition & Health Acquires Oral Health Ingredient
    Coatings World

    Latest Breaking News From Coatings World

    PPG Names Rodolfo Ramirez GM, Packaging Coatings
    Sherwin-Williams Unveils High Performance Interior Marine Decking Systems
    AkzoNobel Appoints Ricardo Rosso as Pontiac Site Manager
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Tracey Technologies Upgrades iTrace Software
    Foster Corporation Rebrands its Distribution Business
    Greenleaf Health Recruits Two Former FDA Officials
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Catawba Research Names Andrew Silverman COO
    Evonik Begins Construction of $220M U.S. Facility for Pharmaceutical Lipids
    PathAI, GSK Partner on Phase II NASH Clinical Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    MAC Revamps 'Back To MAC' Recycling Program
    Coty Names New Chief Commercial Officer for Prestige Division
    GK Launches Vegan Hair Styling Range
    Happi

    Latest Breaking News From Happi

    Jonathan Wormser and Stephen Yaseen Introduce Vegan Genderless Skin Care Brand Good Weird
    MAC Cosmetics Brings Back Improved ‘Back-To-MAC’ Takeback Program
    Sederma Introduces Active Ingredient to Address Pigment Disorders
    Ink World

    Latest Breaking News From Ink World

    INX International Makes Investment in Gooten
    Videojet Launches 1580 C Soft-Pigmented Contrast Printer
    Epson to Showcase Textile, Signage and Aqueous Printers at ISA 2023
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Loftware secures significant growth equity investment
    Avery Dennison’s atma.io adds new ChatGPT and AI features
    Reproflex3 wins regional business award
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Drylock Technologies Plants First trees in Drylock Forest
    A.Celli Group to Hold Open House
    Toray Awarded for Nanodesign Technology
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Report: No Complications With OssDsign Catalyst Graft
    FDA OKs Bioretec's RemeOs Bioresorbable Metal Trauma Screw
    First Clinical Use of Stryker’s Tornier Pyrocarbon Humeral Head
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Universal Display Sponsors, Presents at ICDT 2023
    Miron Washington Joins Impinj Board of Directors
    All-Time High for Global 300MM Semiconductor Capacity in 2026: SEMI

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login